vimarsana.com

Latest Breaking News On - Counterfeit medicines - Page 1 : vimarsana.com

Transcripts for BBCNEWS BBC News Now 20240604 11:39:00

To be clear, they are not used for medical purposes . To be clear, they are not used for medical purposes . No, they are not a roved medical purposes . No, they are not approved for medical purposes . No, they are not approved for human medical purposes . No, they are not approved for human use. Medical purposes . No, they are not approved for human use. The medical purposes . No, they are not approved for human use. The issue | medical purposes . No, they are not. Approved for human use. The issue is that they are approved for human use. The issue is that they are not approved for human use. The issue is that they are not just approved for human use. The issue is that they are notjust being approved for human use. The issue is that they are notjust being sent approved for human use. The issue is that they are notjust being sent to i that they are not just being sent to the uk, presumably this is a global problem. The uk, presumably this is a global roblem. ,. ,. , the uk, presumably t

Issue
Uk
Problem
Human-use
Purposes
Human
Global-roblem
Notjust
Nitazenes
Us
Morphine
Concern

US FDA chief very concerned about fake weight loss drugs

NEW YORK (Reuters) -U.S. Food and Drug Administration Commissioner Dr. Robert Califf said on Wednesday that he is very concerned about the prevalence of compounded and fake versions of highly in demand new weight loss drugs online. Consumers seeking these medicines are attracted to compounded versions that are sold without proper controls to ensure they get the right active drug, Califf said in a Reuters Newsmaker interview. "In the context of the total picture of illicit drugs being sold on the internet, it's almost certainly bigger than, much bigger than what we see," he said of such reports to the agency.

Ahmed-aboulenein
Eli-lilly-zepbound
Novo-nordisk-wegovy
Caroline-humer
Robert-califf
Drug-administration
Reuters
Drug-administration-commissioner
Reuters-newsmaker
Novo-nordisk
Eli-lilly
Bill-berkrot

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.